However, in the animal model of AD, neither Cu chelation nor elevation of Cu via diet had a significant impact on tau pathology (443), and the unifying mechanism of Cu contribution to AD pathogenesis has not yet emerged. This evidence concerns the gene MAPT and Alzheimer disease.